newsfilter
← Latest News
Business Wire·

Gossamer Bio Announces Presentations at the European Respiratory Society (ERS) Congress 2025

- One Oral and Four Poster Presentations Highlight Seralutinib's Potential Across Pulmonary Hypertension and Fibrotic Lung Disease - Gossamer Bio, Inc. (NASDAQ:GOSS), a clinical-stage biopharmaceutical company focused